MEDIDATA
Medidata, a Dassault Systèmes company, provides cloud-based software and data analytics solutions that support the design, planning, execution, and management of clinical trials for life sciences organizations. Its platform is used by pharmaceutical, biotechnology, medical device companies, and contract research organizations to collect, manage, and analyze clinical and real‑world data. Medidata generates revenue through subscription software licenses, data and analytics products, and related professional and support services.
- Clinical Trial & Research Software
- Data Warehousing & Lakes
- Business Intelligence & Dashboards
- Revenue
- $1.2B
- Employees
- 3,500
- Founded
- 1999
- Headquarters
- New York City, United States of America
What 84 Arbolus experts think of MEDIDATA
NPS scores for Medidata are predominantly in the 7–10 range, indicating high satisfaction, with a strong concentration of 8s and 10s. Renewal intent is mostly positive, especially among high and mid spenders; some uncertainty is seen in lower spend brackets. Stickiness is high, with the majority at MoreThan1Year implementation. Expert feedback highlights robust clinical workflows and operational value, but notes configuration complexity and usability as recurring themes.Overall Customer Sentiment: Positive
Who reviewed MEDIDATA
- C-Suite 52% (44)
- Director 35% (29)
- Manager 14% (12)
Employer names and spend open in the full report, along with the other 81 customers.
Everything 84 customers told us about MEDIDATA.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
25 Net Promoter Score, from 82 scored reviews- Promoters 30
- Passives 43
- Detractors 9
Cumulative NPS by month
+0 over 6 months- Mar 8
- Apr 8
- May 8
- Jun 8
- Jul 8
- Sep 8
Net Promoter Score across 4 reviews, accumulated up to each month. Category median 26 across 4 companies.
Praised
- Actionable Automation
- AI-Enhanced Workflows
- Usability Improvements
- Continued Support and Expansion
Criticised
- Competitive Operating Burden
- Support and Commercial Deterioration
- Opaque AI Automation Risk
- Configuration Complexity
What customers say
Renewal intent
Plan to renew 53%Plan to renew, by seniority
- 53% 34 answers
- 52% 23 answers
- 43% 7 answers
- 100% 2 answers
- 8.5/10 Average score from customers who will renew
- 7.8/10 Average score from undecided customers
- 6.1/10 Average score from customers not renewing
Top alternatives
Most weighed by MEDIDATA customersReport
For people who use MEDIDATA
Do you use MEDIDATA at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 84 customers of MEDIDATA have already contributed
Takes a few minutes. Your identity stays anonymous.